Navigation Links
MaxLife Fund Corp. Appoints Mr. Dan Schmitt, Mr. Randy Delkus and Mr. Daniel E. Kahan to its Board of Directors
Date:4/21/2008

the architect of a methodology for creating new business initiatives. He has combined his expertise in business development, administration, finance, and marketing, to create The Incubation Factory - a privately funded business incubator. In 2005, Mr. Schmitt opened the doors to "The Factory" in state of the art renovated 50,000 sq.ft. warehouse in downtown St. Louis. The Incubation Factory is dedicated to the mission of growing businesses faster, smarter, and cheaper than ever thought possible.

Mr. Schmitt earned a B.A. in Marketing from the University of Northern Iowa in 1989. He spends time consulting with each of the businesses while always keeping an eye to the next business opportunity.

Mr. Randy Delkus is a senior healthcare executive with experience in both for profit and not for profit sectors. He received his B.S. in Nursing, Magna Cum Laude, from St. Louis University and also holds a Business degree from Southern Illinois University, specializing in Marketing and Management. He completed his Masters in Business Administration at Webster University in St. Louis, graduating Magna Cum Laude.

Mr. Delkus is currently the President of Anthony, Allan & Quinn (AAQ) and The Incubation Factory (TIF), a go-to market business incubator that works with start up companies, universities, individual entrepreneurs and private and public industry; 75% of its current portfolio has a life sciences and/or healthcare focus.

Prior to AAQ, Mr. Delkus served as Chief Executive Officer for one of St. Louis' most premier healthcare institutions.

Mr. Daniel E. Kahan has an extensive international actuarial background in the life insurance industry. Mr. Kahan has hands-on experience and knowledge of the life settlements market in North America. After earning a B.Sc. (Honors) in Mathematics from University College, London, England, he qualified as an Associate of the Institute of Actuaries in 1984. He worked for 3 years in South Africa for Metropolit
'/>"/>

SOURCE MaxLife Fund Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. MaxLife Fund Corp. and Capital Growth Planning Inc., sign a joint venture agreement
2. MaxLife Fund Corp. retains the Law firm, Anslow & Jaclin, LLP of Manalapan, N.J., to review MaxLife Fund Corp. options to be listed on the NASDAQ Capital Market
3. MaxLife Fund Corp. appoints Daniel E. Kahan, to its Advisory Board
4. MaxLife Fund Corp. purchases a portfolio of Life Settlement Policies with a face value of $4,000,000
5. HMS Holdings Corp. Hosts First Quarter 2008 Financial Teleconference and Presentation
6. Oracle Healthcare Acquisition Corp. Changes Record Date and Date of Special Meeting to Consider and Vote on Dissolution and Plan of Liquidation
7. Eurosport Active World, Corp. Announces Reverse Merger Into Eagle International Holdings Group, Inc.
8. SXC Health Solutions Corp. Commences Exchange Offer For Shares Of National Medical Health Card Systems, Inc.
9. Cantel Medical Corp. and National Safety Council Launch Joint Initiative to Prepare Businesses and Individuals for Flu Pandemic
10. Sharps Compliance Corp. Announces Appointment of Al Aladwani as its Senior Vice President of Operations
11. Response Biomedical Corp. - Year End 2007 Earnings Webcast and Conference Call - March 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...swire-FirstCall/ -- Inverness Medical Innovations,...atient diagnostics, monitoring and health manageme...ce President, Finance, will attend the upcoming RB... held December 10-11, 2008 at the Westin Times Squ... is scheduled for Thursday, December 11, 2008 at ...
(Date:12/4/2008)...d ,idiosyncratic, study finds , , THURS...accine designed to protect against cervical cancer... doses. , That,s the assessment of Australian r...00 doses of the Gardasil vaccine were given to gir..., Gardasil protects against four types of human...
(Date:12/4/2008)...e-USNewswire/ -- Stem cells derived from bone marr...t a disease called epidermolysis bullosa (EB), a d...kin, according to a study pre-published online in ...ety of Hematology. , , Epidermolysis bullo...fragile skin and blistering on touch, akin to thir...
(Date:12/4/2008)...e/ -- Pittsburgh-based Foundation Radiology,Group... to be one of the 50,largest radiology groups in ...,Pittsburgh, FRG has been growing at a brisk pace...eaders and national experts. , In a little ...44th out of,50 nationally, proof that their busin...
Breaking Medicine News(10 mins):Health News:Inverness Medical Innovations to Present at RBC Capital Markets 2008 Healthcare Conference on December 11, 2008 2Health News:Cervical Cancer Vaccine Well Tolerated 2Health News:Bone Marrow-Derived Stem Cells May Offer Novel Therapeutic Option for Skin Disorder 2Health News:Bone Marrow-Derived Stem Cells May Offer Novel Therapeutic Option for Skin Disorder 3Health News:Bone Marrow-Derived Stem Cells May Offer Novel Therapeutic Option for Skin Disorder 4Health News:Foundation Radiology Group Named One of 50 Largest Radiology Groups in the Country 2
...d with good health and vitality. However, just a s...manufacture vitamin D. //It doesn't take much sunl...nly far less than it takes to get a suntan. Recent...rstand the complex motivations involved with UV li...
...Edward Romond reported from two separate trials th...effectively treated with Herceptin therapy using t...ished in the journal The New England Journal of Me... clinical trials, which compared patients getting ...
...search team from Kyoto University have found that ...hances of getting common cold.// The results of th...l of Preventive Medicine. The study was conducted...tween the age group of 18 to 65. The study recrui...
...ply of deceased donor kidneys for transplantation....donor kidney transplants.// A recent paper in the...the insufficient supply of transplantable kidneys,...increase the number of living donor renal transpla...
Other Medicine News:Health News:Trastuzumab therapy effective for Breast cancer patients with Her-2/neu positive 2Health News:Daily Gargling May Prevent Common Colds 2Health News:Strategies To Boost Living Donor Kidney Transplants 2
(Date:12/4/2008)...o Advance to Clinical Trials , , SAN DIEGO,...nc., a biopharmaceutical company focused on the de...nists for the treatment of cancer, respiratory and...initiated a Phase I clinical trial of VTX-2337, a .... The multi-center clinical trial is being conduc...
(Date:12/3/2008)...irstCall/ -- Sangamo BioSciences, Inc.,(Nasdaq: ... update on milestones,achieved in 2008 and previe...and Analyst Briefing to be held in New York City t...a-Aldrich Corporation,s Research,Biotech Business...tial of the,two companies, collaboration to comme...
(Date:12/3/2008)...wswire-FirstCall/ -- Isis Pharmaceuticals,Inc. (...armaceuticals, Inc.,provided positive survival re...,OGX-011 in combination with docetaxel and prednis... prednisone alone ("the control arm") for first-li...state cancer. The current 10.6,month median over...
(Date:12/2/2008)...wswire-FirstCall/ -- Biopure Corporation,(Nasdaq:...cal Research Center,(NMRC) has submitted to the F...tigational new drug (IND) application to conduct a...ic Hemopure(R) [hemoglobin glutamer - 250 (bovine)...rauma patients. The study is,entitled "Operation ...
Breaking Medicine Technology:VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology 2Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 2Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 3Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 4Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 5Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 6Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 2Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 3Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 4U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 2U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 3Methods and Tools Used to Achieve Best Customer Satisfaction 21500 1Methods and Tools Used to Achieve Best Customer Satisfaction 21500 2Miami Institute Launches New Weight Loss Program 21496 1Miami Institute Launches New Weight Loss Program 21496 2Amick Shaw Join S C BlueCross Foundation Board 21492 1Study 3A Quick responses to influenza outbreaks reduces illness and death 21490 1Study 3A Quick responses to influenza outbreaks reduces illness and death 21490 2
...IRE)--Jun 12, 2007 - Results from the,successful c...,OSCI) FACTIVE(R) (gemifloxacin mesylate) tablets ...neumonia of mild to moderate,severity (CAP) have b...ed Journal of Antimicrobial Chemotherapy, currentl...Phase III clinical,trial comparing a five-day and ...
...WIRE)--Jun 12, 2007 - Proprietary Pulsed,Electroma...,Technologies, Inc. (AMEX:II), improved neuron sur...lammation, researchers,reported today in a platfor...(BEMS,http://www.bioelectromagnetics.org) Annual ...iated with neuron death that occurs in,Parkinson,s...
Other Medicine Technology:July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 2July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 3July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 4July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 5Ivivi's PEMF Technology Significantly Improves Neuron Survival in,Parkinson's Disease Model, Study Finds 2Ivivi's PEMF Technology Significantly Improves Neuron Survival in,Parkinson's Disease Model, Study Finds 3
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: